Development of a novel recombinant biotherapeutic with applications in targeted therapy of human arthritis
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of a novel recombinant biotherapeutic with applications in targeted therapy of human arthritis
Authors
Keywords
-
Journal
ARTHRITIS AND RHEUMATISM
Volume 63, Issue 12, Pages 3758-3767
Publisher
Wiley
Online
2011-09-28
DOI
10.1002/art.30650
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Human single-chain variable fragment that specifically targets arthritic cartilage
- (2010) Chris Hughes et al. ARTHRITIS AND RHEUMATISM
- Angiogenesis and vasculogenesis in rheumatoid arthritis
- (2010) Zoltán Szekanecz et al. CURRENT OPINION IN RHEUMATOLOGY
- Quantifying colocalization by correlation: The Pearson correlation coefficient is superior to the Mander's overlap coefficient
- (2010) Jeremy Adler et al. CYTOMETRY PART A
- The vasculature in rheumatoid arthritis: cause or consequence?
- (2010) Ewa M. Paleolog INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTβR
- (2010) Jennifer S. Michaelson et al. mAbs
- Bispecific antibodies for cancer therapy
- (2010) Patrick Chames et al. mAbs
- Colocalization Analysis in Fluorescence Micrographs: Verification of a More Accurate Calculation of Pearson's Correlation Coefficient
- (2010) Andrew L. Barlow et al. MICROSCOPY AND MICROANALYSIS
- The safety and side effects of monoclonal antibodies
- (2010) Trevor T. Hansel et al. NATURE REVIEWS DRUG DISCOVERY
- Golimumab, a human anti-tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis
- (2009) Paul Emery et al. ARTHRITIS AND RHEUMATISM
- Isolation and characterization of human monoclonal antibodies specific to MMP-1A, MMP-2 and MMP-3
- (2009) Stefanie Pfaffen et al. EXPERIMENTAL CELL RESEARCH
- New insights in synovial angiogenesis
- (2009) Zoltán Szekanecz et al. JOINT BONE SPINE
- Are new agents needed to treat RA?
- (2009) Peter E. Lipsky Nature Reviews Rheumatology
- Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis
- (2009) Peter C. Taylor et al. Nature Reviews Rheumatology
- Treatment of rheumatoid arthritis: state of the art 2009
- (2009) Ronald F. van Vollenhoven Nature Reviews Rheumatology
- Engineering of stable bispecific antibodies targeting IL-17A and IL-23
- (2009) Robert Mabry et al. PROTEIN ENGINEERING DESIGN & SELECTION
- A novel model for the pre-clinical imaging of inflamed human synovial vasculature
- (2009) T. Garrood et al. RHEUMATOLOGY
- Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis
- (2009) Kathrin Schwager et al. ARTHRITIS RESEARCH & THERAPY
- Golimumab, a human antibody to tumour necrosis factor given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study
- (2008) E C Keystone et al. ANNALS OF THE RHEUMATIC DISEASES
- Vascular involvement in rheumatic diseases: 'vascular rheumatology'
- (2008) Zoltán Szekanecz et al. ARTHRITIS RESEARCH & THERAPY
- Therapeutic advances in rheumatology with the use of recombinant proteins
- (2008) Achim Rothe et al. Nature clinical practice. Rheumatology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started